United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015
暂无分享,去创建一个
A. Sullivan | S. Bhagani | G. Brook | D. Mutimer | Verity Sullivan | R. Kulasegaram | C. Gore | L. Hesketh | E. Devitt | Elizabeth Hodges | A. Torkington | Simon P. Farnworth
[1] Peter Schmid,et al. Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon‐alpha therapy via mathematical modeling , 2014, Hepatology.
[2] H. Razavi,et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. , 2014, Journal of hepatology.
[3] M. Zoli,et al. Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[4] L. Rostaing,et al. Review: Occult hepatitis C virus infection: Still remains a controversy , 2014, Journal of medical virology.
[5] R. Geskus,et al. Stabilizing Incidence of Hepatitis C Virus Infection Among Men Who Have Sex With Men in Amsterdam , 2014, Journal of acquired immune deficiency syndromes.
[6] L. Sticchi,et al. Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. , 2014, World journal of gastroenterology.
[7] F. Lert,et al. Comparison of risk factors in HIV-infected men who have sex with men, coinfected or not with hepatitis C virus (ANRS VESPA2 French cross-sectional national survey) , 2014, Sexually Transmitted Infections.
[8] V. Soriano,et al. Management and treatment of chronic hepatitis B in HIV-positive patients , 2014, Annals of medicine.
[9] A. Burroughs,et al. Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C , 2014, Hepatology.
[10] A. Flaxman,et al. Global Distribution and Prevalence of Hepatitis C Virus Genotypes , 2014, Hepatology.
[11] Chien-Jen Chen,et al. Epidemiology and natural history of hepatitis C virus infection. , 2014, World journal of gastroenterology.
[12] Su-mei Li,et al. Liver fibrosis evaluation by ARFI and APRI in chronic hepatitis C. , 2014, World journal of gastroenterology.
[13] Y. Rotman,et al. Long‐term therapy of chronic delta hepatitis with peginterferon alfa , 2014, Alimentary pharmacology & therapeutics.
[14] H. Stellbrink,et al. Multiple hepatitis C virus (HCV) reinfections in HIV‐positive men who have sex with men: no influence of HCV genotype switch or interleukin‐28B genotype on spontaneous clearance , 2014, HIV medicine.
[15] S. Mukherjee,et al. Antiviral therapy for chronic hepatitis C in 2014 , 2014, Expert Review of Clinical Pharmacology.
[16] L. Abu-Raddad,et al. Vertical Transmission of Hepatitis C Virus: Systematic Review and Meta-analysis , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] E. Sagnelli,et al. Acute hepatitis C: A 24‐week course of pegylated interferon alpha‐2b versus a 12‐week course of pegylated interferon alpha‐2b alone or with ribavirin , 2014, Hepatology.
[18] G. Guzman,et al. Histological and Clinical Characteristics of Patients with Chronic Hepatitis C and Persistently Normal Alanine Aminotransferase Levels , 2014, Hepatitis research and treatment.
[19] A. Vedio,et al. Successful use of Fendrix in HIV-infected non-responders to standard hepatitis B vaccines. , 2014, The Journal of infection.
[20] A. Localio,et al. Hepatic Decompensation in Antiretroviral-Treated Patients Co-Infected With HIV and Hepatitis C Virus Compared With Hepatitis C VirusMonoinfected Patients , 2014, Annals of Internal Medicine.
[21] R. Geskus,et al. Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995–2010 , 2014, AIDS.
[22] E. Sagnelli,et al. Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment , 2014, Infection.
[23] V. Lee,et al. Experience of acute hepatitis C and HIV co-infection in an inner city clinic in the UK , 2014, Journal of the International AIDS Society.
[24] M. Hellard,et al. High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study , 2013, PloS one.
[25] C. Datz,et al. A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection. , 2013, Journal of hepatology.
[26] C. Leen,et al. British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013 , 2013, HIV medicine.
[27] C. Antoniou,et al. Hepatitis A vaccination and immunological parameters in HIV-infected patients. , 2013, Viral immunology.
[28] A. Alibrandi,et al. Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C. , 2013, Journal of hepatology.
[29] J. Parry,et al. Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study , 2013, BMJ Open.
[30] Felipe García,et al. Factors associated with the immune response to hepatitis A vaccination in HIV-infected patients in the era of highly active antiretroviral therapy. , 2013, Vaccine.
[31] W. Gerlich. Medical Virology of Hepatitis B: how it began and where we are now , 2013, Virology Journal.
[32] Yoshiyuki Suzuki,et al. Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection , 2013, Hepatology.
[33] Priyanka Gupta. Hepatitis C Virus and HIV Type 1 Co-Infection , 2013, Infectious disease reports.
[34] June-Sung Lee,et al. Window period of anti-hepatitis A virus immunoglobulin M antibodies in diagnosing acute hepatitis A , 2013, European journal of gastroenterology & hepatology.
[35] A. Flaxman,et al. Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence , 2013, Hepatology.
[36] C. Sabin,et al. Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997. , 2013, Gastroenterology.
[37] A. Sullivan,et al. 2012 BASHH statement on partner notification for sexually transmissible infections , 2013, International journal of STD & AIDS.
[38] W. Kim,et al. 43 LONG TERM TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY AND THE RISK OF HEPATOCELLULAR CARCINOMA , 2013 .
[39] P. Gautret,et al. Outbreaks associated to large open air festivals, including music festivals, 1980 to 2012. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[40] R. Chou,et al. Reducing Risk for Mother-to-Infant Transmission of Hepatitis C Virus: A Systematic Review for the U.S. Preventive Services Task Force , 2013, Annals of Internal Medicine.
[41] C. Hoebe,et al. Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous non-responders. , 2012, Vaccine.
[42] N. Chavez-Tapia,et al. Clinical course and management of acute hepatitis A infection in adults. , 2012, Annals of hepatology.
[43] T. Berg,et al. The predictive value of IL28B gene polymorphism for spontaneous clearance in a single source outbreak cohort is limited in patients carrying the CCR5Δ32 mutation. , 2011, Journal of hepatology.
[44] H. Harris,et al. The impact of mode of acquisition on biological markers of paediatric hepatitis C virus infection , 2011, Journal of viral hepatitis.
[45] S. Degli Esposti,et al. Hepatitis B in pregnancy: challenges and treatment. , 2011, Gastroenterology clinics of North America.
[46] Yong-hua Zhao,et al. Lamivudine treatment is associated with improved survival in fulminant hepatitis B , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[47] F. Baldelli,et al. Severe Acute Hepatitis B Treated With Entecavir. , 2011, Mediterranean journal of hematology and infectious diseases.
[48] M. Fisher. Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conference. , 2011, AIDS.
[49] M. Robles,et al. Impact of Acute Hepatitis A Virus (HAV) Infection on HIV Viral Load in HIV-Infected Patients and Influence of HIV Infection on Acute HAV Infection , 2011, Journal of the International Association of Physicians in AIDS Care.
[50] R. Majdzadeh,et al. Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. , 2010, Vaccine.
[51] Hyo‐suk Lee,et al. Hepatitis A: Clinical Manifestations and Management , 2010, Intervirology.
[52] R. Coutinho,et al. Viral hepatitis among men who have sex with men, epidemiology and public health consequences. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[53] Ryan Stone,et al. Worry as a window into the lives of people who use injection drugs: a factor analysis approach , 2009, Harm reduction journal.
[54] F. Allerberger,et al. Foodborne outbreak of hepatitis A, November 2007–January 2008, Austria , 2009, European Journal of Clinical Microbiology & Infectious Diseases.
[55] J. Gregory,et al. Hepatitis a outbreak epidemiologically linked to a food handler in Melbourne, Victoria. , 2009, Communicable diseases intelligence quarterly report.
[56] E. Thomson,et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV , 2009, AIDS.
[57] R. Geskus,et al. Trends in Hepatitis A, B, and Shigellosis Compared With Gonorrhea and Syphilis in Men Who Have Sex With Men in Amsterdam, 1992–2006 , 2008, Sexually Transmitted Diseases.
[58] N. Crowcroft,et al. Outbreaks of hepatitis A in England and Wales associated with two co‐circulating hepatitis A virus strains , 2008, Journal of medical virology.
[59] M. Pichichero,et al. Improving vaccine delivery using novel adjuvant systems , 2008, Human vaccines.
[60] J. Macías,et al. High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack , 2008, Liver international : official journal of the International Association for the Study of the Liver.
[61] H. Tillmann,et al. Telbivudine versus lamivudine in patients with chronic hepatitis B. , 2008, The New England journal of medicine.
[62] C. Morissette,et al. Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review , 2008, Journal of viral hepatitis.
[63] F. Diaz-Mitoma,et al. Long-term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescents. , 2008, Vaccine.
[64] G. Rezza,et al. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis , 2008, Journal of Epidemiology & Community Health.
[65] R. Cheung,et al. Diagnostic markers for hepatitis virus infection. , 2008, Expert opinion on medical diagnostics.
[66] G. Dusheiko,et al. Therapeutic strategies in the management of patients with chronic hepatitis B virus infection. , 2008, The Lancet. Infectious diseases.
[67] A. Lok,et al. Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations. , 2008, Journal of hepatology.
[68] M. Hussain,et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London , 2008, Journal of medical virology.
[69] G. Fattovich,et al. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. , 2008, Journal of hepatology.
[70] R. D. de Man,et al. A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients. , 2008, The Journal of infectious diseases.
[71] E. Gambineri,et al. Higher risk of hepatitis C virus perinatal transmission from drug user mothers is mediated by peripheral blood mononuclear cell infection , 2008, Journal of medical virology.
[72] L. Paitoonpong,et al. Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy , 2008, Scandinavian journal of infectious diseases.
[73] N. Stupiansky,et al. Relations between sexually transmitted infection diagnosis and sexual compulsivity in a community-based sample of men who have sex with men , 2007, Sexually Transmitted Infections.
[74] William M. Lee,et al. Acute liver failure: Summary of a workshop , 2007, Hepatology.
[75] P. Marcellin,et al. Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial. , 2007, Annals of internal medicine.
[76] M. Mondelli,et al. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: A seventeen‐year prospective cohort study , 2007, Hepatology.
[77] E Jenny Heathcote,et al. Antiviral therapy: chronic hepatitis C , 2007, Journal of viral hepatitis.
[78] M. Gambarin-Gelwan. Hepatitis B in pregnancy. , 2007, Clinics in liver disease.
[79] H. Lamba,et al. Increasing hepatitis A IgG prevalence rate in men who have sex with men attending a sexual health clinic in London: implications for immunization policy , 2007, International journal of STD & AIDS.
[80] C. Beyrer,et al. Vaccine immunogenicity in injecting drug users: a systematic review. , 2007, The Lancet. Infectious diseases.
[81] Víctor Agulló Calatayud,et al. How can hepatitis C be prevented in the long term? , 2007, The International journal on drug policy.
[82] H. Thomas,et al. Best practice in the treatment of chronic hepatitis B: a summary of the European Viral Hepatitis Educational Initiative (EVHEI). , 2007, Journal of hepatology.
[83] R. D. de Man,et al. Exacerbation of chronic hepatitis B infection after delivery , 2007, Journal of viral hepatitis.
[84] L. Leibovici,et al. Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta‐analysis , 2007, Journal of viral hepatitis.
[85] M. Harris,et al. Symptomatology and health attitudes of chronic hepatitis B patients in the USA , 2007, Journal of viral hepatitis.
[86] R. Coutinho,et al. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users , 2007, Addiction.
[87] A. Celis,et al. Hepatitis C antibody intraassay correlation: is retest in duplicate necessary? , 2007, Transfusion.
[88] A. Singal,et al. Mechanisms of Synergy Between Alcohol and Hepatitis C Virus , 2007, Journal of clinical gastroenterology.
[89] J. Rodríguez-Baño,et al. Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapy , 2007, Hepatology.
[90] L. Goldani,et al. Hepatitis C virus (HCV) viremia in HIV‐infected patients without HCV antibodies detectable by third‐generation enzyme immunoassay , 2007, Journal of gastroenterology and hepatology.
[91] Y. Benhamou. Hepatitis B in the HIV-Coinfected Patient , 2007, Journal of acquired immune deficiency syndromes.
[92] J. Zuckerman. Review: hepatitis B immune globulin for prevention of hepatitis B infection , 2007, Journal of medical virology.
[93] H. Ward,et al. Update on lymphogranuloma venereum in the United Kingdom , 2007, Sexually Transmitted Infections.
[94] J. Kaldor,et al. High rates of sexually transmitted infections in HIV positive homosexual men: data from two community based cohorts , 2007, Sexually Transmitted Infections.
[95] N. Leung,et al. Disease progression in Chinese chronic hepatitis C patients with persistently normal alanine aminotransaminase levels , 2007, Alimentary pharmacology & therapeutics.
[96] S. Tortu,et al. Individual and couple-level risk factors for hepatitis C infection among heterosexual drug users: a multilevel dyadic analysis. , 2007, The Journal of infectious diseases.
[97] P. van Damme,et al. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults. , 2007, Travel medicine and infectious disease.
[98] Z. Younossi,et al. Fatigue and Health-Related Quality of Life (HRQL) in Chronic Hepatitis C Virus Infection , 2007, Digestive Diseases and Sciences.
[99] R. Pintó,et al. Molecular epidemiological studies show that hepatitis A virus is endemic among active homosexual men in Europe , 2007, Journal of medical virology.
[100] M. Kundi. New hepatitis B vaccine formulated with an improved adjuvant system , 2007, Expert review of vaccines.
[101] G. Alexander,et al. Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type? , 2007, Journal of viral hepatitis.
[102] R. Wallace. Clinical audit of gastrointestinal conditions occurring among adults with Down syndrome attending a specialist clinic , 2007, Journal of intellectual & developmental disability.
[103] K. Herck,et al. A review of the long-term protection after hepatitis A and B vaccination. , 2007 .
[104] H. Whittle,et al. Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early life. , 2007, Vaccine.
[105] G. Forster,et al. The use of the super accelerated hepatitis B vaccination regimen in a north London sexual assault referral centre (SARC). , 2007, Journal of forensic and legal medicine.
[106] F. D. De Rosa,et al. A short course of pegylated interferon‐α in acute HCV hepatitis , 2007 .
[107] M. Kundi,et al. Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population. , 2007, Vaccine.
[108] C. Paterson,et al. Sharps injuries in UK health care: a review of injury rates, viral transmission and potential efficacy of safety devices. , 2006, Occupational medicine.
[109] M. Van Ranst,et al. Viral interaction and clinical implications of coinfection of hepatitis C virus with other hepatitis viruses , 2006, European journal of gastroenterology & hepatology.
[110] M. Manns,et al. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV. , 2006, Journal of hepatology.
[111] V. Johnson,et al. Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127 , 2006, Hepatology.
[112] R. Bruno,et al. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection , 2006, AIDS.
[113] D. Prati. Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. , 2006, Journal of hepatology.
[114] R. Levine,et al. Assessment of fibrosis progression in untreated irish women with chronic hepatitis C contracted from immunoglobulin anti-D. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[115] N. Wright,et al. A review of the evidence for the effectiveness of primary prevention interventions for Hepatitis C among injecting drug users , 2006, Harm Reduction Journal.
[116] W. Ho,et al. Drug abuse, innate immunity and hepatitis C virus , 2006, Reviews in medical virology.
[117] E. Schiff,et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[118] S. Sookoian. Liver disease during pregnancy: acute viral hepatitis. , 2006, Annals of hepatology.
[119] M. Colombo,et al. The natural history of compensated cirrhosis due to hepatitis C virus: A 17‐year cohort study of 214 patients , 2006, Hepatology.
[120] E. Sagnelli,et al. Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[121] A. Folgori,et al. Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years , 2006, Journal of viral hepatitis.
[122] R. Harrington,et al. An outbreak of hepatitis B virus infection among methamphetamine injectors: the role of sharing injection drug equipment. , 2006, Addiction.
[123] C. Thio. Diagnosis, Diagnostic Tests and Monitoring of Hepatitis B Virus in Monoinfected and HIV-Coinfected Patients , 2006, Antiviral therapy.
[124] E. Elinav,et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. , 2006, Gastroenterology.
[125] S. Lemon,et al. Hepatitis A virus: From discovery to vaccines , 2006, Hepatology.
[126] S. Palmer,et al. Exposure to school children as a risk factor in a community outbreak of hepatitis A in young adults: a case control study , 2005, Epidemiology and Infection.
[127] N. Andrews,et al. Survival of a national cohort of hepatitis C virus infected patients, 16 years after exposure , 2005, Epidemiology and Infection.
[128] W. Powderly,et al. Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[129] A MarioCalvo,et al. Antibody levels and protection after hepatitis B vaccination: Results of a 15-year follow-up , 2005 .
[130] Morris Sherman1. Hepatocellular Carcinoma: Epidemiology, Risk Factors, and Screening , 2005 .
[131] A. Barone,et al. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. , 2005, Vaccine.
[132] M. Newell,et al. When does mother to child transmission of hepatitis C virus occur? , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.
[133] A. Zanetti,et al. Lack of Evidence of Sexual Transmission of Hepatitis C among Monogamous Couples: Results of a 10-Year Prospective Follow-Up Study , 2004, American Journal of Gastroenterology.
[134] W. Stremmel,et al. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C. , 2003, Zeitschrift fur Gastroenterologie.
[135] B. Bell,et al. Outbreak of hepatitis A among men who have sex with men: implications for hepatitis A vaccination strategies. , 2003, The Journal of infectious diseases.
[136] J. Castilla,et al. Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples , 2003, Sexually transmitted infections.
[137] COST-EFFECTIVENESS IMPLICATIONS OF THE TIMING OF ANTIRETROVIRAL THERAPY IN HIV-INFECTED ADULTS , 2002 .
[138] B. Woodruff,et al. Prevalence of hepatitis virus infections in an institution for persons with developmental disabilities. , 2002, American journal of mental retardation : AJMR.
[139] J. Ross,et al. Seroprevalence of hepatitis A immunity in male genitourinary medicine clinic attenders: a case control study of heterosexual and homosexual men , 2002, Sexually transmitted infections.
[140] V. Arankalle,et al. Vertical transmission of Hepatitis A , 2002, Indian journal of pediatrics.
[141] A. Hansell,et al. An outbreak of hepatitis A among young men associated with having sex in public venues. , 2001, Communicable disease and public health.
[142] J. Villeneuve,et al. Fulminant Hepatitis A in Patients with Chronic Liver Disease , 2000, Canadian journal of public health = Revue canadienne de sante publique.
[143] Ding‐Shinn Chen,et al. Low incidence of hepatitis C virus transmission between spouses: A prospective study , 2000, Journal of gastroenterology and hepatology.
[144] C. Pramoolsinsap. Acute hepatitis A and acquired immunity to hepatitis A virus in hepatitis B virus (HBV) carriers and in HBV‐ or hepatitis C virus‐related chronic liver diseases in Thailand , 2000, Journal of viral hepatitis.
[145] B. Robertson,et al. Excretion of Hepatitis A Virus (HAV) in Adults: Comparison of Immunologic and Molecular Detection Methods and Relationship between HAV Positivity and Infectivity in Tamarins , 1999, Journal of Clinical Microbiology.
[146] H. Ward,et al. Risky business: health and safety in the sex industry over a 9 year period. , 1999, Sexually transmitted infections.
[147] R. Corona,et al. Lack of evidence for increased risk of hepatitis A infection in homosexual men , 1999, Epidemiology and Infection.
[148] A. Floreani,et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis , 1999, Cancer.
[149] A. Tärnvik,et al. Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose. , 1999, Vaccine.
[150] D. Carrington,et al. Outbreak of hepatitis B in an acupuncture clinic. , 1999, Communicable disease and public health.
[151] J. Löwer,et al. A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool , 1999, Journal of medical virology.
[152] H. Whittle,et al. What level of hepatitis B antibody is protective? , 1999, The Journal of infectious diseases.
[153] F. Chang,et al. Evidence of transmission of hepatitis B virus to spouses from sequence analysis of the viral genome , 1998, Journal of gastroenterology and hepatology.
[154] T. Kutlu,et al. A case of vertical transmission of hepatitis A virus infection , 1998, Acta paediatrica.
[155] B. Bell,et al. Hepatitis A virus infections associated with clotting factor concentrate in the United States , 1998, Transfusion.
[156] C. Loveday,et al. Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage. , 1998, Sexually transmitted infections.
[157] J. Kruppenbacher,et al. Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance. , 1997, Vaccine.
[158] P. Goldwater. Randomized, comparative trial of 20 μg vs 40 μg Engerix B vaccine in hepatitis B vaccine non-responders , 1997 .
[159] H. Yotsuyanagi,et al. Chronic hepatitis A with persistent viral replication , 1996, Journal of medical virology.
[160] M. Cramp,et al. Seroprevalence of Hepatitis B and C Virus in Two Institutions Caring for Mentally Handicapped Adults , 1996, Journal of the Royal Society of Medicine.
[161] K. Hyams. Risks of chronicity following acute hepatitis B virus infection: a review. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[162] A. Oxman,et al. Partner notification for sexually transmitted diseases: an overview of the evidence. , 1994, Canadian journal of public health = Revue canadienne de sante publique.
[163] K. Neal,et al. Risk factors for hepatitis C virus infection. A case-control study of blood donors in the Trent Region (UK) , 1994, Epidemiology and Infection.
[164] J. Hoofnagle. Chronic hepatitis B. , 1990, The New England journal of medicine.
[165] K. Hyams,et al. Hepatitis B in a highly active prostitute population: evidence for a low risk of chronic antigenemia. , 1990, The Journal of infectious diseases.
[166] J. Giesecke,et al. Heterosexual contact as a major route for transmission of acute hepatitis B among adults. , 1990, The Journal of infection.
[167] F. di Nola,et al. [Viral hepatitis and pregnancy]. , 1967, Minerva medica.
[168] S. H.E.HARRI. Survival of a national cohort of hepatitis C virus infected patients , 16 years after exposure , 2012 .
[169] E. Thomson,et al. Diagnosing acute hepatitis C in HIV-infected patients: nucleic acid testing compared with antibody and antigen-antibody detecting methods. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[170] [EASL clinical practice guidelines. Management of chronic hepatitis B]. , 2009, Gastroenterologie clinique et biologique.
[171] J. Keystone,et al. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule. , 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[172] S. Sauleda,et al. The changing epidemiology of hepatitis C virus infection in Europe. , 2008, Journal of hepatology.
[173] N. Khardori. Humoral and Cellular Immune Responses to a Hepatitis B Vaccine Booster 15–18 Years after Neonatal Immunization , 2008 .
[174] G. Liss,et al. Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B , 2008 .
[175] F. D. De Rosa,et al. A short course of pegylated interferon-alpha in acute HCV hepatitis. , 2007, Journal of viral hepatitis.
[176] B. Connor,et al. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule. , 2007, Journal of travel medicine.
[177] P. van Damme,et al. A review of the long-term protection after hepatitis A and B vaccination. , 2007, Travel medicine and infectious disease.
[178] R. P. Myers,et al. Antiviral Therapy for Chronic Hepatitis B , 2007, Annals of Internal Medicine.
[179] Y. Benhamou. Treatment algorithm for chronic hepatitis B in HIV-infected patients. , 2006, Journal of hepatology.
[180] D. Thabut,et al. Natural history and predictors of disease severity in chronic hepatitis C. , 2006, Journal of hepatology.
[181] M. Sherman. Hepatocellular carcinoma: epidemiology, risk factors, and screening. , 2005, Seminars in liver disease.
[182] G. Ippolito,et al. European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[183] S. Kashiwagi,et al. Hepatitis C virus infection in institutionalized psychiatric patients: possible role of transmission by razor sharing. , 2000, Digestive diseases and sciences.
[184] 鈴木 智彦. Characterization of hepatitis B virus surface antigen-specific CD4+ T cells in hepatitis B vaccine non-responders , 2000 .
[185] R. Reintjes,et al. Outbreak of hepatitis A in Rotterdam associated with visits to 'darkrooms' in gay bars. , 1999, Communicable disease and public health.
[186] P. Goldwater. Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-responders. , 1997, Vaccine.
[187] D. Palmović,et al. Prevention of hepatitis B virus (HBV) infection in health-care workers after accidental exposure: A comparison of two prophylactic schedules , 1993, Infection.
[188] H. Margolis,et al. Worldwide epidemiology of hepatitis A virus infection. , 1993, Journal of hepatology.